Isomorphic Labs Raises $2.1 Billion Series B to Push Its AI Drug Design Engine Toward Human Trials
Isomorphic Labs, the Alphabet-owned AI drug discovery company built on the legacy of DeepMind's AlphaFold research, announced on May 12,...
Isomorphic Labs, the Alphabet-owned AI drug discovery company built on the legacy of DeepMind's AlphaFold research, announced on May 12,...
Google is teaming up with Singapore-based microbiome company AMILI to launch a personalized nutrition app called AMILI Optimise, one that...
Woebot Health, one of the earliest and best-known AI therapy chatbots, shut down its consumer cognitive behavioral therapy (CBT) service...
Wysa, an AI-led mental health conversational agent delivered through a smartphone app, has received FDA Breakthrough Device Designation for use...
A study published in JAMA Network Open has found that ambient AI scribes — software that listens to patient visits...
Chai Discovery, a startup building generative AI models for pre-clinical drug design, announced on July 14, 2026 that it raised...
Xsolis, a healthcare AI and analytics company whose software helps more than 600 hospitals and health insurers make utilization-review and...
A robot named Abi, tested in a senior care home in Melbourne, Australia in 2025, is now making its way...
Most evidence for AI-assisted mammography has come from controlled trials or retrospective research studies. Germany's PRAIM program is different: it's...
Researchers at Imperial College London published a study in Nature Cancer in 2026 evaluating version 1.2 of a Google mammography...